Fe65-PTB2 Dimerization Mimics Fe65-APP Interaction

Physiological function and pathology of the Alzheimer’s disease causing amyloid precursor protein (APP) are correlated with its cytosolic adaptor Fe65 encompassing a WW and two phosphotyrosine-binding domains (PTBs). The C-terminal Fe65-PTB2 binds a large portion of the APP intracellular domain (AIC...

Full description

Bibliographic Details
Main Authors: Lukas P. Feilen, Kevin Haubrich, Paul Strecker, Sabine Probst, Simone Eggert, Gunter Stier, Irmgard Sinning, Uwe Konietzko, Stefan Kins, Bernd Simon, Klemens Wild
Format: Article
Language:English
Published: Frontiers Media S.A. 2017-05-01
Series:Frontiers in Molecular Neuroscience
Subjects:
Online Access:http://journal.frontiersin.org/article/10.3389/fnmol.2017.00140/full
_version_ 1831771459725295616
author Lukas P. Feilen
Kevin Haubrich
Kevin Haubrich
Paul Strecker
Sabine Probst
Simone Eggert
Gunter Stier
Irmgard Sinning
Uwe Konietzko
Stefan Kins
Bernd Simon
Klemens Wild
author_facet Lukas P. Feilen
Kevin Haubrich
Kevin Haubrich
Paul Strecker
Sabine Probst
Simone Eggert
Gunter Stier
Irmgard Sinning
Uwe Konietzko
Stefan Kins
Bernd Simon
Klemens Wild
author_sort Lukas P. Feilen
collection DOAJ
description Physiological function and pathology of the Alzheimer’s disease causing amyloid precursor protein (APP) are correlated with its cytosolic adaptor Fe65 encompassing a WW and two phosphotyrosine-binding domains (PTBs). The C-terminal Fe65-PTB2 binds a large portion of the APP intracellular domain (AICD) including the GYENPTY internalization sequence fingerprint. AICD binding to Fe65-PTB2 opens an intra-molecular interaction causing a structural change and altering Fe65 activity. Here we show that in the absence of the AICD, Fe65-PTB2 forms a homodimer in solution and determine its crystal structure at 2.6 Å resolution. Dimerization involves the unwinding of a C-terminal α-helix that mimics binding of the AICD internalization sequence, thus shielding the hydrophobic binding pocket. Specific dimer formation is validated by nuclear magnetic resonance (NMR) techniques and cell-based analyses reveal that Fe65-PTB2 together with the WW domain are necessary and sufficient for dimerization. Together, our data demonstrate that Fe65 dimerizes via its APP interaction site, suggesting that besides intra- also intermolecular interactions between Fe65 molecules contribute to homeostatic regulation of APP mediated signaling.
first_indexed 2024-12-22T07:59:41Z
format Article
id doaj.art-1f8fb131998b4e0886bb287a66fd4d8a
institution Directory Open Access Journal
issn 1662-5099
language English
last_indexed 2024-12-22T07:59:41Z
publishDate 2017-05-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Molecular Neuroscience
spelling doaj.art-1f8fb131998b4e0886bb287a66fd4d8a2022-12-21T18:33:17ZengFrontiers Media S.A.Frontiers in Molecular Neuroscience1662-50992017-05-011010.3389/fnmol.2017.00140262305Fe65-PTB2 Dimerization Mimics Fe65-APP InteractionLukas P. Feilen0Kevin Haubrich1Kevin Haubrich2Paul Strecker3Sabine Probst4Simone Eggert5Gunter Stier6Irmgard Sinning7Uwe Konietzko8Stefan Kins9Bernd Simon10Klemens Wild11Heidelberg University Biochemistry Center (BZH), University of HeidelbergHeidelberg, GermanyHeidelberg University Biochemistry Center (BZH), University of HeidelbergHeidelberg, GermanyEuropean Molecular Biology Laboratory (EMBL), Structural and Computational BiologyHeidelberg, GermanyDivision of Human Biology and Human Genetics, University of KaiserslauternKaiserslautern, GermanyInstitute for Regenerative Medicine (IREM), University of ZurichZurich, SwitzerlandDivision of Human Biology and Human Genetics, University of KaiserslauternKaiserslautern, GermanyHeidelberg University Biochemistry Center (BZH), University of HeidelbergHeidelberg, GermanyHeidelberg University Biochemistry Center (BZH), University of HeidelbergHeidelberg, GermanyInstitute for Regenerative Medicine (IREM), University of ZurichZurich, SwitzerlandDivision of Human Biology and Human Genetics, University of KaiserslauternKaiserslautern, GermanyEuropean Molecular Biology Laboratory (EMBL), Structural and Computational BiologyHeidelberg, GermanyHeidelberg University Biochemistry Center (BZH), University of HeidelbergHeidelberg, GermanyPhysiological function and pathology of the Alzheimer’s disease causing amyloid precursor protein (APP) are correlated with its cytosolic adaptor Fe65 encompassing a WW and two phosphotyrosine-binding domains (PTBs). The C-terminal Fe65-PTB2 binds a large portion of the APP intracellular domain (AICD) including the GYENPTY internalization sequence fingerprint. AICD binding to Fe65-PTB2 opens an intra-molecular interaction causing a structural change and altering Fe65 activity. Here we show that in the absence of the AICD, Fe65-PTB2 forms a homodimer in solution and determine its crystal structure at 2.6 Å resolution. Dimerization involves the unwinding of a C-terminal α-helix that mimics binding of the AICD internalization sequence, thus shielding the hydrophobic binding pocket. Specific dimer formation is validated by nuclear magnetic resonance (NMR) techniques and cell-based analyses reveal that Fe65-PTB2 together with the WW domain are necessary and sufficient for dimerization. Together, our data demonstrate that Fe65 dimerizes via its APP interaction site, suggesting that besides intra- also intermolecular interactions between Fe65 molecules contribute to homeostatic regulation of APP mediated signaling.http://journal.frontiersin.org/article/10.3389/fnmol.2017.00140/fullFe65phosphotyrosine-binding domain (PTB)homodimerizationamyloid precursor protein (APP)AICDAlzheimer’s disease
spellingShingle Lukas P. Feilen
Kevin Haubrich
Kevin Haubrich
Paul Strecker
Sabine Probst
Simone Eggert
Gunter Stier
Irmgard Sinning
Uwe Konietzko
Stefan Kins
Bernd Simon
Klemens Wild
Fe65-PTB2 Dimerization Mimics Fe65-APP Interaction
Frontiers in Molecular Neuroscience
Fe65
phosphotyrosine-binding domain (PTB)
homodimerization
amyloid precursor protein (APP)
AICD
Alzheimer’s disease
title Fe65-PTB2 Dimerization Mimics Fe65-APP Interaction
title_full Fe65-PTB2 Dimerization Mimics Fe65-APP Interaction
title_fullStr Fe65-PTB2 Dimerization Mimics Fe65-APP Interaction
title_full_unstemmed Fe65-PTB2 Dimerization Mimics Fe65-APP Interaction
title_short Fe65-PTB2 Dimerization Mimics Fe65-APP Interaction
title_sort fe65 ptb2 dimerization mimics fe65 app interaction
topic Fe65
phosphotyrosine-binding domain (PTB)
homodimerization
amyloid precursor protein (APP)
AICD
Alzheimer’s disease
url http://journal.frontiersin.org/article/10.3389/fnmol.2017.00140/full
work_keys_str_mv AT lukaspfeilen fe65ptb2dimerizationmimicsfe65appinteraction
AT kevinhaubrich fe65ptb2dimerizationmimicsfe65appinteraction
AT kevinhaubrich fe65ptb2dimerizationmimicsfe65appinteraction
AT paulstrecker fe65ptb2dimerizationmimicsfe65appinteraction
AT sabineprobst fe65ptb2dimerizationmimicsfe65appinteraction
AT simoneeggert fe65ptb2dimerizationmimicsfe65appinteraction
AT gunterstier fe65ptb2dimerizationmimicsfe65appinteraction
AT irmgardsinning fe65ptb2dimerizationmimicsfe65appinteraction
AT uwekonietzko fe65ptb2dimerizationmimicsfe65appinteraction
AT stefankins fe65ptb2dimerizationmimicsfe65appinteraction
AT berndsimon fe65ptb2dimerizationmimicsfe65appinteraction
AT klemenswild fe65ptb2dimerizationmimicsfe65appinteraction